陈凤林院长独创的《习惯性流产的分类、诊断和治疗标准》获得国内、国际共18个国家的专利技术(1.“免疫性反复自然流产的诊断方法和治疗监测方法”注：已在中国、欧洲、美国申请专利，中国申请号为200480029919.8，欧洲申请号为04712989.5-2404，美国申请号为10/586,285，国际申请号为PCT/CN2004/000134);2.“反复自然流产的治疗药物及治疗方法”注：已在中国、欧洲、美国申请专利，中国申请号200480029918.3，欧洲申请号为04712990.3-2107，美国申请号为10/585,623，国际申请号为PCT/CN2004/000135)。 这标志着中国不孕不育治疗机构与国际水平接轨，达到并超过了世界先进水平。

President Chenfenglin's original "Classification, Diagnosis, and Treatment Standards for Customary miscarriage" has obtained patent technology from 18 countries in China and the world(1. Note: Patent applications have been filed in China, Europe and the United States, China application number is 20048002919.8, Europe application number is 04712989.5-2404, and the United States application number is 10/586,285. The international application number is PCT/CN2004/000134); 2. Note: Patent applications have been filed in China, Europe and the United States, China application number is 2004792918.3, Europe application number is 04712990.3 -2107, and the United States application number is 10/585,623. The international application number is PCT/CN2004/000135). This indicates that China's infertility treatment institutions are in line with the international standards and have reached and surpassed the world's advanced levels.

关于反复自然流产专利技术的声明 Statement on patent technology for repeated spontaneous miscarriage

安太专利技术反复自然流产(习惯性流产)诊断和治疗技术，已经获国内和国际专利。目前为止，我们没有向任何单位和个人转让，也没有其他合作单位。

Antai patent technology repeated spontaneous miscarriage(habitual miscarriage) diagnosis and treatment technology, has been domestic and international patents. So far, we have not transferred to any units or individuals, nor have we any other cooperation units.